Cargando…

A 5-year recurrence-free survivor with over ten colorectal liver metastases undergoing FOLFOX plus bevacizumab followed by two-stage hepatectomy

A 62-year-old male was admitted because of lower left abdominal pain and diarrhea. The patient was diagnosed with rectal cancer and multiple liver metastases. First, the laparoscopic Hartmann operation with a D3 lymph node dissection was performed. After five cycles of folinic acid, 5-fluorouracil a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamaoki, Yuka, Beppu, Toru, Sakamoto, Yasuo, Imai, Katsunori, Hayashi, Hiromitsu, Nitta, Hidetoshi, Hashimoto, Daisuke, Miyamoto, Yuji, Tsuruta, Yutaka, Chikamoto, Akira, Baba, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626468/ https://www.ncbi.nlm.nih.gov/pubmed/26943435 http://dx.doi.org/10.1186/s40792-015-0113-6

Ejemplares similares

Irinotecan Plus S-1 Followed by Hepatectomy for a Patient with Initially Unresectable Colorectal Liver Metastases, Who Showed Severe Drug Rash with Oxaliplatin Plus 5-FU and Leucovorin (FOLFOX)
por: Komori, Hiroyuki, et al.
Publicado: (2014)

Intra-aortic balloon pump-assisted major hepatectomy in a case with coronary disease
por: Okadome, Kazuo, et al.
Publicado: (2015)

Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
por: Miyata, Tatsunori, et al.
Publicado: (2021)

Varied application of intercostal trans-diaphragmatic ports for laparoscopic hepatectomy
por: Hayashi, Hiromitsu, et al.
Publicado: (2020)

Successful treatment for sorafenib-induced liver dysfunction: a report of case with liver biopsy
por: Kuroda, Daisuke, et al.
Publicado: (2016)

Reactive lymphoid hyperplasia of the liver requires differential diagnosis of hepatocellular carcinoma
por: Higashi, Takaaki, et al.
Publicado: (2015)

Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer
por: Sakamoto, Keita, et al.
Publicado: (2015)

Hepatic angiomyolipoma with special attention to radiologic imaging
por: Kuramoto, Kunitaka, et al.
Publicado: (2015)

Co-occurrence of liver metastasis of gastrointestinal stromal tumor and hepatocellular carcinoma: a case report
por: Yamashita, Kohei, et al.
Publicado: (2016)

Colon cancer metastasis mimicking intraductal papillary neoplasm of the extra-hepatic bile duct
por: Yamao, Takanobu, et al.
Publicado: (2015)

The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma
por: Beppu, Toru, et al.
Publicado: (2017)

Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model
por: Kuroki, H, et al.
Publicado: (2015)

Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma
por: Okabe, Hirohisa, et al.
Publicado: (2018)

C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA
por: Kaida, Takayoshi, et al.
Publicado: (2016)

Hepatic sclerosed hemangioma with special attention to diffusion-weighted magnetic resonance imaging
por: Miyata, Tatsunori, et al.
Publicado: (2018)

Ongoing 5-year+ survival after multiple metastasectomies, followed by CAPOX plus bevacizumab, for metastatic colorectal cancer
por: Matsuishi, Kozue, et al.
Publicado: (2020)

Accessory right hepatic artery branched from gastroduodenal artery
por: Yamashita, Kohei, et al.
Publicado: (2015)

Prognostic Impact of Surgical Margin Width in Hepatectomy for Colorectal Liver Metastasis
por: Sakamoto, Katsunori, et al.
Publicado: (2023)

Lysyl oxidase induces epithelial‐mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma
por: Umezaki, Naoki, et al.
Publicado: (2019)

Optimal patient selection for successful two‐stage hepatectomy of bilateral colorectal liver metastases
por: Imai, Katsunori, et al.
Publicado: (2021)

Successful surgical internal drainage of postoperative pancreatic pseudocyst through pancreaticojejunostomy with distal pancreatectomy: a case report
por: Sakata, Kazuya, et al.
Publicado: (2015)

Surgery for metastatic tumors of the pancreas
por: Yagi, Taisuke, et al.
Publicado: (2017)

A case of successful transarterial stenting for pseudoaneurysm after pancreaticoduodenectomy
por: Kitamura, Fumimasa, et al.
Publicado: (2020)

Idiosyncratic drug‐induced liver injury: A short review
por: Yamashita, Yo‐ichi, et al.
Publicado: (2017)

A long survivor with local relapse of hilar cholangiocarcinoma after R1 surgery treated with chemoradiotherapy: a case report and literature review
por: Okabe, Hirohisa, et al.
Publicado: (2016)

Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
por: Koga, Yuki, et al.
Publicado: (2018)

FOLFOX‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors
por: Lacombe, Caroline, et al.
Publicado: (2023)

Successful surgical rescue of delayed onset diaphragmatic hernia following radiofrequency ablation using a thoracoscopic approach for hepatocellular carcinoma: a case report
por: Morito, Atsushi, et al.
Publicado: (2021)

Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer
por: Cunningham, D, et al.
Publicado: (2013)

Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma
por: Beppu, Toru, et al.
Publicado: (2020)

Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer
por: Baba, H, et al.
Publicado: (2012)

EZH2 Is Associated with Malignant Behavior in Pancreatic IPMN via p27(Kip1) Downregulation
por: Kuroki, Hideyuki, et al.
Publicado: (2014)

A Case of Appendiceal Adenocarcinoma with Clinical Benefit from FOLFOX and Bevacizumab
por: Powell, Erin D., et al.
Publicado: (2009)

Cost-effectiveness of FOLFOX6+Bevacizumab Versus FOLFOX6+Cetuximab in Stage IV Colorectal Cancer Patients in Shiraz, Iran
por: Jafari, Abdosaleh, et al.
Publicado: (2023)

Carcinosarcoma of Vater’s papilla: case report of a rare neoplasm and review of the literature
por: Itoyama, Rumi, et al.
Publicado: (2019)

Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial
por: Takahashi, Takao, et al.
Publicado: (2022)

Predictive model for postoperative pleural effusion after hepatectomy
por: Nitta, Hidetoshi, et al.
Publicado: (2020)

Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab
por: Matsunaga, Mototsugu, et al.
Publicado: (2016)

miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
por: Higashi, T, et al.
Publicado: (2015)

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
por: Wang, Feng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_32pa98anl53qpt1nktmocu63t3